Most Recent

image: Bringing the Internet of Things into the Lab

Bringing the Internet of Things into the Lab

By Abby Olena | June 1, 2018

The IoT can link up many facets of research—from laboratory equipment to ideas—but scientists must be ready for the questions its implementation could raise.

1 Comment

With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.

0 Comments

image: Flux and Uncertainty in the CRISPR Patent Landscape

Flux and Uncertainty in the CRISPR Patent Landscape

By Aggie Mika | October 1, 2017

The battle for the control of the intellectual property surrounding CRISPR-Cas9 is as storied and nuanced as the technology itself.

0 Comments

image: Accessing Drugs for Medical Aid-in-Dying

Accessing Drugs for Medical Aid-in-Dying

By Catherine Offord | August 17, 2017

A fraught market for the barbiturates prescribed to terminally ill patients who choose to end their lives has physicians turning to options outside big pharma.

0 Comments

image: Learning from Iceland’s Model for Genetic Research

Learning from Iceland’s Model for Genetic Research

By Catherine Offord | June 1, 2017

The Scandinavian island’s unique combination of genetic homogeneity, genealogical tradition, and high participation in research make it a prime location for discovery and validation of drug targets.

1 Comment

image: Making CAR T-Cell Therapy Safer

Making CAR T-Cell Therapy Safer

By Catherine Offord | April 1, 2017

Following a spate of patient deaths in clinical trials testing modified T cells for the treatment of cancer, researchers work to reduce the treatment’s toxicity without sacrificing efficacy.

0 Comments

image: Pharma Cooperates to Achieve Precision Medicine

Pharma Cooperates to Achieve Precision Medicine

By Catherine Offord | February 1, 2017

The challenges of adapting drug development to the age of personalized therapies encourage collaboration among industry players.

0 Comments

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By Catherine Offord | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

image: Pet Meds Adapted from Human Therapies

Pet Meds Adapted from Human Therapies

By Jenny Rood | October 1, 2016

Companies focused on developing treatments for dogs, cats, and horses are bringing a diverse array of products to the pet medicine market.

0 Comments

image: The Growth of Iowa Biotech

The Growth of Iowa Biotech

By Jenny Rood | August 1, 2016

The state’s industry draws inspiration from medicine as well as agriculture.

1 Comment

Popular Now

  1. Two University of Rochester Professors Resign in Protest
  2. Dartmouth Professor Investigated for Sexual Misconduct Retires
  3. Theranos Leaders Indicted For Fraud
    The Nutshell Theranos Leaders Indicted For Fraud

    Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.

  4. Koko the Signing Gorilla Dies at 46